29/04/2026
"We're thrilled to join Parexel and further scale our proven technology and our experienced team as we strengthen pharmacovigilance solutions. Together, we can offer improved efficiency, quality and compliance for our customers worldwide," shared Mohit Gupta, President and CEO, Vitrana, in the Parexel press release.
Read more: https://www.globenewswire.com/NewsRoom/ReleaseNg/7571800
📢 Breaking News: Today Parexel announced it has acquired Vitrana, a provider of an AI-enabled, end-to-end pharmacovigilance (PV) technology platform. The acquisition further expands Parexel's technology capabilities to better serve customers.
"With Vitrana, we can now offer customers a single partner for both PV technology and services – and that changes what we can deliver for them. Our customers will benefit from best-in-class, technology-enabled PV services that handle growing regulatory volume and complexity, enhance compliance, streamline workflows, and free experts to focus on what matters most: product and patient safety," said Sanjay Vyas, President of Patient Safety Services & Clinical Logistics and Managing Director of India, Parexel.
Read more in the press release: https://brnw.ch/21x23q9
